For patients using GLP-1 medications for type 2 diabetes, hemoglobin A1c may increase after discontinuation if no alternative therapy is initiated, with the magnitude varying based on individual factors and baseline therapy
FDA-approved GLP-1 medications are administered via subcutaneous injection (semaglutide, liraglutide, dulaglutide, tirzepatide) into the abdomen, thigh, or upper arm, or taken orally as Rybelsus
It helps manage blood sugar levels and has been noted for its additional benefit of promoting weight loss
In the refining and purification stage of the active pharmaceutical ingredient (API), our company has adopted pH gradient crystallization method
To make up for this, your pancreas pumps out even more insulin
Patients who maintain consistent weekly injections on the same day throughout treatment see meaningfully better results than those who are inconsistent, even if each individual missed dose seems minor